Pre-clinical
Jun 17, 2015
Chimeric Antigen Receptor T-cell Therapy Landscape
In the field of oncology, no other approach is as attentive as Immunotherapy. Renewed interest in immunotherapy has been driven by Chimeric Antigen Receptor (CAR) T-cell therapy. This emerging approach is (CAR) T-cell technology which is showing great promise in immunotherapy. There are 35+ products in pipeline and...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
